Philippe Moingeon

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Knee Osteoarthritis

Coronavirus Disease

Top Venues

Expert review of clinical immunology

Medecine sciences : M/S

Nature medicine

Expert opinion on drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Philippe Moingeon
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases. Expert review of clinical immunology (2024)
Philippe Moingeon
[Artificial intelligence-driven drug development against autoimmune diseases]. Medecine sciences : M/S 40 (5) (2024)
Philippe Moingeon
[Artificial intelligence-driven drug development against autoimmune diseases]. Medecine sciences : M/S 40 (5) (2024)
Philippe Moingeon
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases. Expert review of clinical immunology (2024)
Laurence Laigle, Loubna Chadli, Philippe Moingeon
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert review of clinical immunology 19 (3) (2023)
Laurence Laigle, Loubna Chadli, Philippe Moingeon
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert review of clinical immunology 19 (3) (2023)
Laurence Laigle, Loubna Chadli, Philippe Moingeon
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert review of clinical immunology 19 (3) (2023)
Laurence Laigle, Loubna Chadli, Philippe Moingeon
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert review of clinical immunology (2023)
Laurence Laigle, Loubna Chadli, Philippe Moingeon
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert review of clinical immunology 19 (3) (2023)
Laurence Laigle, Loubna Chadli, Philippe Moingeon
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert review of clinical immunology (2023)
Mickaël Guedj, Jack Swindle, Antoine Hamon, Sandra Hubert, Emiko Desvaux, Jessica Laplume, Laura Xuereb, Céline Lefebvre, Yannick Haudry, Christine Gabarroca, Audrey Aussy, Laurence Laigle, Isabelle Dupin-Roger, Philippe Moingeon
Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platform. Expert opinion on drug discovery 17 (8) (2022)
Jean-Baptiste Schiratti, Rémy Dubois, Paul Herent, David Cahané, Jocelyn Dachary, Thomas Clozel, Gilles Wainrib, Florence Keime-Guibert, Agnes Lalande, Maria Pueyo, Romain Guillier, Christine Gabarroca, Philippe Moingeon
A deep learning method for predicting knee osteoarthritis radiographic progression from MRI. Arthritis research & therapy 23 (1) (2021)
Emiko Desvaux, Antoine Hamon, Sandra Hubert, Cheïma Boudjeniba, Bastien Chassagnol, Jack Swindle, Audrey Aussy, Laurence Laigle, Jessica Laplume, Perrine Soret, Pierre Jean-François, Isabelle Dupin-Roger, Mickaël Guedj, Philippe Moingeon
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19. PloS one 16 (7) (2021)
Perrine Soret, Christelle Le Dantec, Emiko Desvaux, Nathan Foulquier, Bastien Chassagnol, Sandra Hubert, Christophe Jamin, Guillermo Barturen, Guillaume Desachy, Valérie Devauchelle-Pensec, Cheïma Boudjeniba, Divi Cornec, Alain Saraux, Sandrine Jousse-Joulin, Nuria Barbarroja, Ignasi Rodríguez-Pintó, Veerle Ide, Lorenzo Beretta, Carlo Chizzolini, László Kovács, Torsten Witte, null null, null null, Eléonore Bettacchioli, Anne Buttgereit, Zuzanna Makowska, Ralf Lesche, Maria Orietta Borghi, Javier Martin, Sophie Courtade-Gaiani, Laura Xuereb, Mickaël Guedj, Philippe Moingeon, Marta Eugenia Alarcón-Riquelme, Laurence Laigle, Jacques-Olivier Pers
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome. Nature communications 12 (1) (2021)
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, Miguel Muñoz-Ruiz, Duncan R McKenzie, Thomas S Hayday, Isaac Francos-Quijorna, Shraddha Kamdar, Magdalene Joseph, Daniel Davies, Richard Davis, Aislinn Jennings, Iva Zlatareva, Pierre Vantourout, Yin Wu, Vasiliki Sofra, Florencia Cano, Maria Greco, Efstathios Theodoridis, Joshua D Freedman, Sarah Gee, Julie Nuo En Chan, Sarah Ryan, Eva Bugallo-Blanco, Pärt Peterson, Kai Kisand, Liis Haljasmägi, Loubna Chadli, Philippe Moingeon, Lauren Martinez, Blair Merrick, Karen Bisnauthsing, Kate Brooks, Mohammad A A Ibrahim, Jeremy C Mason, Federico Lopez Gomez, Kola Babalola, Sultan Abdul-Jawad, John Cason, Christine Mant, Jeffrey Seow, Carl Graham, Katie J Doores, Francesca Di Rosa, Jonathan Edgeworth, Manu Shankar-Hari, Adrian C Hayday
A dynamic COVID-19 immune signature includes associations with poor prognosis. Nature medicine 26 (10) (2020)